Chromosome 22q11.2 deletion syndrome, distal

disease
On this page

Also known as distal 22q11.2 microdeletion syndromedistal del(22)(q11.2)distal monosomy 22q11.2

Summary

Chromosome 22q11.2 deletion syndrome, distal (MONDO:0012740) is a disease with 10 cohort genes.

At a glance

  • Prevalence: Unknown (Worldwide)
  • Cohort genes: 10
  • ClinVar variants: 13
  • Phenotypes (HPO): 60

Clinical features

Signs & symptoms

Clinical features (HPO)

60 HPO clinical features (Orphanet curated; top 50 by frequency):

HPO IDTermFrequency
HP:0000319Smooth philtrumVery frequent (80-99%)
HP:0001249Intellectual disabilityVery frequent (80-99%)
HP:0001263Global developmental delayVery frequent (80-99%)
HP:0001622Premature birthVery frequent (80-99%)
HP:0002463Language impairmentVery frequent (80-99%)
HP:0002553Highly arched eyebrowVery frequent (80-99%)
HP:0004322Short statureVery frequent (80-99%)
HP:0000219Thin upper lip vermilionFrequent (30-79%)
HP:0000252MicrocephalyFrequent (30-79%)
HP:0000307Pointed chinFrequent (30-79%)
HP:0000363Abnormality of earlobeFrequent (30-79%)
HP:0000430Underdeveloped nasal alaeFrequent (30-79%)
HP:0000490Deeply set eyeFrequent (30-79%)
HP:0001511Intrauterine growth retardationFrequent (30-79%)
HP:0001660Truncus arteriosusFrequent (30-79%)
HP:0001763Pes planusFrequent (30-79%)
HP:0001802Absent toenailFrequent (30-79%)
HP:0001817Absent fingernailFrequent (30-79%)
HP:0002664NeoplasmFrequent (30-79%)
HP:0004209Clinodactyly of the 5th fingerFrequent (30-79%)
HP:0000010Recurrent urinary tract infectionsOccasional (5-29%)
HP:0000023Inguinal herniaOccasional (5-29%)
HP:0000160Narrow mouthOccasional (5-29%)
HP:0000175Cleft palateOccasional (5-29%)
HP:0000272Malar flatteningOccasional (5-29%)
HP:0000276Long faceOccasional (5-29%)
HP:0000324Facial asymmetryOccasional (5-29%)
HP:0000407Sensorineural hearing impairmentOccasional (5-29%)
HP:0000426Prominent nasal bridgeOccasional (5-29%)
HP:0000453Choanal atresiaOccasional (5-29%)
HP:0000581BlepharophimosisOccasional (5-29%)
HP:0000657Oculomotor apraxiaOccasional (5-29%)
HP:0000716DepressionOccasional (5-29%)
HP:0000722Compulsive behaviorsOccasional (5-29%)
HP:0001166ArachnodactylyOccasional (5-29%)
HP:0001250SeizureOccasional (5-29%)
HP:0001510Growth delayOccasional (5-29%)
HP:0001629Ventricular septal defectOccasional (5-29%)
HP:0001631Atrial septal defectOccasional (5-29%)
HP:0001659Aortic regurgitationOccasional (5-29%)
HP:0001770Toe syndactylyOccasional (5-29%)
HP:0001852Sandal gapOccasional (5-29%)
HP:0002021Pyloric stenosisOccasional (5-29%)
HP:0002205Recurrent respiratory infectionsOccasional (5-29%)
HP:0002607Bowel incontinenceOccasional (5-29%)
HP:0002673Coxa valgaOccasional (5-29%)
HP:0002705High, narrow palateOccasional (5-29%)
HP:0002721ImmunodeficiencyOccasional (5-29%)
HP:0003307HyperlordosisOccasional (5-29%)
HP:0004279Short palmOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namechromosome 22q11.2 deletion syndrome, distal
Mondo IDMONDO:0012740
MeSHC567511
OMIM611867
Orphanet261330
DOIDDOID:0060413
SNOMED CT734029004
UMLSC2678480
MedGen395634
GARD0017245
Is cancer (heuristic)no

Also known as: chromosome 22q11.2 deletion syndrome, distal · distal 22q11.2 microdeletion syndrome · distal del(22)(q11.2) · distal monosomy 22q11.2

Data availability: 13 ClinVar variants.

Disease family

Classification path: disease › human disease › disease by body system or component › nervous system disordercongenital nervous system disorder22q11.2 deletion syndromechromosome 22q11.2 deletion syndrome, distal

Related subtypes (3): congenital unilateral hypoplasia of depressor anguli oris, DiGeorge syndrome, velocardiofacial syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

13 retrieved; paginated sample, class counts are floors:

11 pathogenic, 1 uncertain significance, 1 likely pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
4820242Single alleleAIFM3Pathogeniccriteria provided, single submitter
599193NC_000022.10:g.21808950_22963000del1154051CCDC116Pathogeniccriteria provided, single submitter
830215NC_000022.10:g.(21822774_21914652)_(22922798_23025613)delCCDC116Pathogeniccriteria provided, single submitter
1330197GRCh37/hg19 22q11.21(chr22:18660135-21737597)x1DGCR6Pathogeniccriteria provided, single submitter
625626GRCh37/hg19 22q11.21-11.23(chr22:21797384-23630313)IGLC1Pathogeniccriteria provided, single submitter
2580309GRCh37/hg19 22q11.21(chr22:18893838-21416074)x3KLHL22Pathogeniccriteria provided, single submitter
2580299GRCh37/hg19 22q11.21(chr22:20609932-21576553)x1LZTR1Pathogeniccriteria provided, single submitter
1703235Single alleleMRPL40Pathogeniccriteria provided, single submitter
2580291GRCh37/hg19 22q11.21(chr22:18893838-20508931)x3MRPL40Pathogeniccriteria provided, single submitter
2663782NC_000022.10:g.(?21797384)(23630313_?)delPRAMEPathogeniccriteria provided, single submitter
973580NC_000022.10:g.21514655_22986816delRIMBP3BPathogeniccriteria provided, single submitter
3384223GRCh37/hg19 22q11.22-11.23(chr22:22989174-23657759)x1IGLC1Likely pathogenicno assertion criteria provided
1339957NM_001089.3(ABCA3):c.4868C>T (p.Ala1623Val)ABCA3Uncertain significancecriteria provided, multiple submitters, no conflicts

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 0 · Orphanet: 9 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
ABCA3Orphanet:2032Idiopathic pulmonary fibrosis
ABCA3Orphanet:217563Neonatal acute respiratory distress syndrome
ABCA3Orphanet:440402Interstitial lung disease due to ABCA3 deficiency
ABCA3Orphanet:685082Pediatric acute respiratory distress syndrome
LZTR1Orphanet:251576Gliosarcoma
LZTR1Orphanet:251579Giant cell glioblastoma
LZTR1Orphanet:2678Familial isolated café-au-lait macules
LZTR1Orphanet:648Noonan syndrome
LZTR1Orphanet:93921Full schwannomatosis

Cohort genes → proteins

10 cohort genes, 10 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence10

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
MRPL40HGNC:14491ENSG00000185608Q9NQ50Large ribosomal subunit protein mL40clinvar
KLHL22HGNC:25888ENSG00000099910Q53GT1Kelch-like protein 22clinvar
AIFM3HGNC:26398ENSG00000183773Q96NN9Apoptosis-inducing factor 3clinvar
CCDC116HGNC:26688ENSG00000161180Q8IYX3Coiled-coil domain-containing protein 116clinvar
DGCR6HGNC:2846ENSG00000183628Q14129Protein DGCR6clinvar
ABCA3HGNC:33ENSG00000167972Q99758Phospholipid-transporting ATPase ABCA3clinvar
RIMBP3BHGNC:33891ENSG00000274600A6NNM3RIMS-binding protein 3Bclinvar
IGLC1HGNC:5855ENSG00000211675P0CG04Immunoglobulin lambda constant 1clinvar
LZTR1HGNC:6742ENSG00000099949Q8N653Leucine-zipper-like transcriptional regulator 1clinvar
PRAMEHGNC:9336ENSG00000185686P78395Melanoma antigen preferentially expressed in tumorsclinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
KLHL22Kelch-like protein 22Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex required for chromosome alignment and localization of PLK1 at kinetochores.
AIFM3Apoptosis-inducing factor 3Induces apoptosis through a caspase dependent pathway.
DGCR6Protein DGCR6May play a role in neural crest cell migration into the third and fourth pharyngeal pouches.
ABCA3Phospholipid-transporting ATPase ABCA3Catalyzes the ATP-dependent transport of phospholipids such as phosphatidylcholine and phosphoglycerol from the cytoplasm into the lumen side of lamellar bodies, in turn participates in the lamellar bodies biogenesis and homeostasis of pul…
RIMBP3BRIMS-binding protein 3BProbable component of the manchette, a microtubule-based structure which plays a key role in sperm head morphogenesis during late stages of sperm development.
IGLC1Immunoglobulin lambda constant 1Constant region of immunoglobulin light chains.
LZTR1Leucine-zipper-like transcriptional regulator 1Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates ubiquitination of Ras (K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS).
PRAMEMelanoma antigen preferentially expressed in tumorsSubstrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, which mediates ubiquitination of target proteins, leading to their degradation.

Protein-family classification

Druggable: 3 · Difficult: 0 · Unknown: 7 · Druggable fraction: 0.3

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Antibody/Immunoglobulin25.8×0.132
Transporter17.8×0.182
Other/Unknown71.2×0.284

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
MRPL40Other/UnknownnoRibosomal_mL40, Ribosomal_mL40_metazoa/plant
KLHL22Other/UnknownnoBTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf
AIFM3Other/UnknownnoFAD/NAD-linked_Rdtase_dimer_sf, Rieske_2Fe-2S, FAD/NAD-binding_dom
CCDC116Other/UnknownnoDUF4702
DGCR6Other/UnknownnoGonadal
ABCA3TransporteryesABC_transporter-like_ATP-bd, AAA+_ATPase, ABC2_TM
RIMBP3BAntibody/ImmunoglobulinyesSH3_domain, FN3_dom, Ig-like_fold
IGLC1Antibody/ImmunoglobulinyesIg/MHC_CS, Ig_C1-set, Ig-like_dom
LZTR1Other/UnknownnoBTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf
PRAMEOther/UnknownnoPRAME, LRR_dom_sf, LRRC14/PRAME

Expression context

Cohort genes with no expression data: 0.

8 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)10
unknown0

Top tissues across cohort

TissueCohort genes
left testis3
right hemisphere of cerebellum2
mucosa of transverse colon2
male germ line stem cell (sensu Vertebrata) in testis2
right testis2
testis2
biceps brachii1
heart right ventricle1
skeletal muscle tissue of rectus abdominis1
cerebellar cortex1
cerebellar hemisphere1
right frontal lobe1
gastrocnemius1
hindlimb stylopod muscle1
skeletal muscle tissue1
lower lobe of lung1
upper lobe of left lung1
upper lobe of lung1
duodenum1
rectum1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
MRPL40292ubiquitousmarkerskeletal muscle tissue of rectus abdominis, biceps brachii, heart right ventricle
KLHL22246ubiquitousyesright hemisphere of cerebellum, cerebellar hemisphere, cerebellar cortex
AIFM3180tissue_specificmarkermucosa of transverse colon, right frontal lobe, right hemisphere of cerebellum
CCDC116146tissue_specificyesleft testis, male germ line stem cell (sensu Vertebrata) in testis, right testis
DGCR6134ubiquitousmarkerskeletal muscle tissue, hindlimb stylopod muscle, gastrocnemius
ABCA3222ubiquitousmarkerlower lobe of lung, upper lobe of lung, upper lobe of left lung
RIMBP3B37markermale germ line stem cell (sensu Vertebrata) in testis, left testis, testis
IGLC1126tissue_specificmarkerduodenum, rectum, mucosa of transverse colon
LZTR1134ubiquitousmarkersural nerve, pituitary gland, adenohypophysis
PRAME117broadmarkerright testis, left testis, testis

Protein interactions among cohort

Intra-cohort edges: 4.

Hub genes (top 10 by interactor count)

SymbolInteractor count
MRPL402,393
AIFM32,051
PRAME1,804
LZTR11,562
ABCA31,436
KLHL221,428
CCDC116633
DGCR6581
RIMBP3B485
IGLC118

Intra-cohort edges

ABSources
AIFM3KLHL22string_interaction
AIFM3LZTR1biogrid_interaction, string_interaction
CCDC116RIMBP3Bstring_interaction
DGCR6MRPL40string_interaction

Structural data

PDB: 6 · AlphaFold-only: 4 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
MRPL40Q9NQ5082
AIFM3Q96NN97
KLHL22Q53GT14
IGLC1P0CG043
LZTR1Q8N6533
ABCA3Q997582

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
DGCR6Q1412986.83
PRAMEP7839581.29
RIMBP3BA6NNM359.08
CCDC116Q8IYX350.59

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 24. Enrichment computed across 10 evidence-associated genes (3 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 3 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Defective ABCA3 causes SMDP313806.7×0.003ABCA3
Metabolism of proteins312.4×0.004MRPL40, KLHL22, ABCA3
Diseases associated with surfactant metabolism1951.7×0.006ABCA3
ABC transporters in lipid homeostasis1200.3×0.024ABCA3
ABC transporter disorders1146.4×0.027ABCA3
Surfactant metabolism1122.8×0.028ABCA3
Disorders of transmembrane transporters146.4×0.045ABCA3
Mitochondrial translation145.9×0.045MRPL40
Mitochondrial translation initiation142.3×0.045MRPL40
Mitochondrial translation elongation142.3×0.045MRPL40
Mitochondrial ribosome-associated quality control140.9×0.045MRPL40
ABC-family protein mediated transport140.5×0.045ABCA3
Mitochondrial translation termination136.6×0.046MRPL40
Diseases of metabolism126.8×0.059ABCA3
Class I MHC mediated antigen processing & presentation123.4×0.063KLHL22
Translation120.7×0.067MRPL40
Neddylation115.8×0.083KLHL22
Antigen processing: Ubiquitination & Proteasome degradation112.4×0.099KLHL22
Adaptive Immune System19.9×0.117KLHL22
Transport of small molecules18.4×0.131ABCA3
Post-translational protein modification16.4×0.162KLHL22
Disease14.4×0.214ABCA3
Immune System14.3×0.214KLHL22

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 9 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
positive regulation of protein homooligomerization11872.4×0.025ABCA3
regulation of phosphatidylcholine metabolic process1936.2×0.025ABCA3
xenobiotic export from cell1624.1×0.025ABCA3
positive regulation of phospholipid efflux1468.1×0.025ABCA3
regulation of lipid biosynthetic process1312.1×0.025ABCA3
organelle assembly1312.1×0.025ABCA3
positive regulation of T cell mediated immune response to tumor cell1267.5×0.025KLHL22
positive regulation of phospholipid transport1267.5×0.025ABCA3
negative regulation of retinoic acid receptor signaling pathway1170.2×0.031PRAME
phosphatidylglycerol metabolic process1156.0×0.031ABCA3
cellular response to L-leucine1156.0×0.031KLHL22
phospholipid homeostasis1110.1×0.034ABCA3
xenobiotic transmembrane transport1104.0×0.034ABCA3
xenobiotic transport193.6×0.034ABCA3
surfactant homeostasis189.2×0.034ABCA3
phosphatidylcholine metabolic process189.2×0.034ABCA3
execution phase of apoptosis185.1×0.034AIFM3
phospholipid transport178.0×0.034ABCA3
immunoglobulin mediated immune response178.0×0.034IGLC1
negative regulation of Ras protein signal transduction174.9×0.034LZTR1
proteasome-mediated ubiquitin-dependent protein catabolic process211.6×0.034KLHL22, PRAME
positive regulation of cholesterol efflux169.3×0.035ABCA3
mitotic spindle assembly checkpoint signaling162.4×0.037KLHL22
negative regulation of type I interferon production155.1×0.040KLHL22
mitotic sister chromatid segregation153.5×0.040KLHL22
positive regulation of T cell activation149.3×0.042KLHL22
B cell receptor signaling pathway144.6×0.044IGLC1
protein monoubiquitination138.2×0.050KLHL22
response to glucocorticoid136.0×0.051ABCA3
fertilization134.7×0.051RIMBP3B

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 10

Druggability breadth: 0 of 10 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
MRPL4000
KLHL2200
AIFM300
CCDC11600
DGCR600
ABCA300
RIMBP3B00
IGLC100
LZTR100
PRAME00

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Pharmacogenomics

Cohort genes with a PharmGKB record: 10; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug2ABCA3, IGLC1
DDruggable family + AlphaFold only, no drug1RIMBP3B
EDifficult family or no structure, no drug7MRPL40, KLHL22, AIFM3, CCDC116, DGCR6, LZTR1, PRAME

Undrugged target profiles

10 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
MRPL400
KLHL220
AIFM30
CCDC1160
DGCR60
ABCA30
RIMBP3B0
IGLC10
LZTR10
PRAME0

Clinical trials & evidence

Clinical trials

Clinical trials: 0.